These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 27791270)

  • 1. Contributions of 3D Cell Cultures for Cancer Research.
    Ravi M; Ramesh A; Pattabhi A
    J Cell Physiol; 2017 Oct; 232(10):2679-2697. PubMed ID: 27791270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer Cytokines and the Relevance of 3D Cultures for Studying Those Implicated in Human Cancers.
    Maddaly R; Subramaniyan A; Balasubramanian H
    J Cell Biochem; 2017 Sep; 118(9):2544-2558. PubMed ID: 28262975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer stem cell targeted therapy: progress amid controversies.
    Wang T; Shigdar S; Gantier MP; Hou Y; Wang L; Li Y; Shamaileh HA; Yin W; Zhou SF; Zhao X; Duan W
    Oncotarget; 2015 Dec; 6(42):44191-206. PubMed ID: 26496035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target.
    Yan Y; Zuo X; Wei D
    Stem Cells Transl Med; 2015 Sep; 4(9):1033-43. PubMed ID: 26136504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meeting Report: The 8th Barossa Meeting-Cell Signaling in Cancer Medicine in the Barossa Valley, Australia.
    Gomez GA; Woodcock JM; Tergaonkar V; Gregory PA
    Cell Death Dis; 2018 Feb; 9(3):284. PubMed ID: 29449550
    [No Abstract]   [Full Text] [Related]  

  • 6. Isolation, identification, and characterization of cancer stem cells: A review.
    Abbaszadegan MR; Bagheri V; Razavi MS; Momtazi AA; Sahebkar A; Gholamin M
    J Cell Physiol; 2017 Aug; 232(8):2008-2018. PubMed ID: 28019667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of epithelial-mesenchymal transition and cancer stem cells.
    Topcul M; Cetin I
    J BUON; 2016; 21(2):312-9. PubMed ID: 27273939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-Dimensional Cell Cultures as an In Vitro Tool for Prostate Cancer Modeling and Drug Discovery.
    Fontana F; Raimondi M; Marzagalli M; Sommariva M; Gagliano N; Limonta P
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32948069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer stem cells: a step toward the cure.
    Boman BM; Wicha MS
    J Clin Oncol; 2008 Jun; 26(17):2795-9. PubMed ID: 18539956
    [No Abstract]   [Full Text] [Related]  

  • 10. Pathophysiologically relevant in vitro tumor models for drug screening.
    Das V; Bruzzese F; Konečný P; Iannelli F; Budillon A; Hajdúch M
    Drug Discov Today; 2015 Jul; 20(7):848-55. PubMed ID: 25908576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Life is three dimensional-as in vitro cancer cultures should be.
    Levinger I; Ventura Y; Vago R
    Adv Cancer Res; 2014; 121():383-414. PubMed ID: 24889536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enrichment of cancer stem cell-like cells by culture in alginate gel beads.
    Xu XX; Liu C; Liu Y; Yang L; Li N; Guo X; Sun GW; Ma XJ
    J Biotechnol; 2014 May; 177():1-12. PubMed ID: 24607645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer drug discovery: recent innovative approaches to tumor modeling.
    Lovitt CJ; Shelper TB; Avery VM
    Expert Opin Drug Discov; 2016 Sep; 11(9):885-94. PubMed ID: 27454169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dark side of ZNF217, a key regulator of tumorigenesis with powerful biomarker value.
    Cohen PA; Donini CF; Nguyen NT; Lincet H; Vendrell JA
    Oncotarget; 2015 Dec; 6(39):41566-81. PubMed ID: 26431164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-parametric hydrogels support 3D in vitro bioengineered microenvironment models of tumour angiogenesis.
    Bray LJ; Binner M; Holzheu A; Friedrichs J; Freudenberg U; Hutmacher DW; Werner C
    Biomaterials; 2015; 53():609-20. PubMed ID: 25890757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of endogenous human stem cell-associated retroviruses (SCARs) and therapy-resistant phenotypes of malignant tumors.
    Glinsky GV
    Cancer Lett; 2016 Jul; 376(2):347-59. PubMed ID: 27084523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Highly expressed NRSN2 is related to malignant phenotype in ovarian cancer.
    Tang W; Ren A; Xiao H; Sun H; Li B
    Biomed Pharmacother; 2017 Jan; 85():248-255. PubMed ID: 27908706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro three-dimensional (3D) models in cancer research: an update.
    Kimlin LC; Casagrande G; Virador VM
    Mol Carcinog; 2013 Mar; 52(3):167-82. PubMed ID: 22162252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microfluidics Enabled Bottom-Up Engineering of 3D Vascularized Tumor for Drug Discovery.
    Agarwal P; Wang H; Sun M; Xu J; Zhao S; Liu Z; Gooch KJ; Zhao Y; Lu X; He X
    ACS Nano; 2017 Jul; 11(7):6691-6702. PubMed ID: 28614653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer research using organoid technology.
    Kretzschmar K
    J Mol Med (Berl); 2021 Apr; 99(4):501-515. PubMed ID: 33057820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.